Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Apr;113(2):287-302.
doi: 10.1111/j.1471-4159.2010.06604.x. Epub 2010 Jan 20.

Basal ganglia pathology in schizophrenia: dopamine connections and anomalies

Emma Perez-Costas  1 , Miguel Melendez-Ferro, Rosalinda C Roberts
Affiliations
Review

Basal ganglia pathology in schizophrenia: dopamine connections and anomalies

Emma Perez-Costas et al. J Neurochem. 2010 Apr.

Abstract

Schizophrenia is a severe mental illness that affects 1% of the world population. The disease usually manifests itself in early adulthood with hallucinations, delusions, cognitive and emotional disturbances and disorganized thought and behavior. Dopamine was the first neurotransmitter to be implicated in the disease, and though no longer the only suspect in schizophrenia pathophysiology, it obviously plays an important role. The basal ganglia are the site of most of the dopamine neurons in the brain and the target of anti-psychotic drugs. In this review, we will start with an overview of basal ganglia anatomy emphasizing dopamine circuitry. Then, we will review the major deficits in dopamine function in schizophrenia, emphasizing the role of excessive dopamine in the basal ganglia and the link to psychosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Electron micrographs of tyrosine hydroxylase (TH) immunocytochemistry in postmortem human caudate nucleus. Several synaptic arrangements are shown. Note that the synapses formed by the TH-labeled synapses are short in length and non-perforated. A) TH-labeled axons (straight black arrows outlined in black) are adjacent to unlabeled axon terminals (at) that are forming asymmetric synapses (black arrows). A TH-labeled terminal makes a symmetric synapse (curved white arrow outlined in black). B) Boxed area in panel A is enlarged to show the symmetric synapse. C) Three TH-labeled boutons (black arrow with white outline) are adjacent to a spine which receives a symmetric TH-labeled synapse (curved white arrow outlined in black) and an asymmetric synapse (black arrow) from an unlabeled terminal (at). D) TH-labeled axon makes a symmetric synapse (arrow) en passant with a dendrite (den). Sp, spines. Scale bars in A-D: 0.5µm. Figures A, B and D are modifications of our previously published figure 1 from Roberts et al., (2009), while Figure C is a modification of our previously published figure 4 from Kung et al., (1998).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abercrombie ED, DeBoer P. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism. J. Neurosci. 1997;17:8498–8505. - PMC - PubMed
    1. Abi-Dargham A, Gil R, Krystal J, Baldwin R, Seibyl J, Bowers M, van Dyck CH, Charney DS, Innis RB, Laruelle M. Increased striatal dopamine transmission in schizophrenia: Confirmation in a second cohort. Am. J. Psychiatry. 1998;155:761–767. - PubMed
    1. Abi-Dargham A, Rodenhiser J, Printz D, et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc. Natl. Acad. Sci. U.SA. 2000;97:8104–8109. - PMC - PubMed
    1. Abi-Dargham A, van de Giessen E, Slifstein M, Kegeles LS, Laruelle M. Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects. Biol. Psychiatry. 2009;65:1091–1093. - PubMed
    1. Akil M, Edgar CL, Pierri JN, Casali S, Lewis DA. Decreased density of tyrosine hydroxylase immunoreactive axons in the entorhinal cortex of schizophrenic subjects. Biol. Psychiatry. 2000;47:361–370. - PubMed

Publication types